Triple
T13786174
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Ryan Haight |
E331261
|
entity |
| Predicate | hasNameGivenTo |
P94429
|
FINISHED |
| Object | Ryan Haight Online Pharmacy Consumer Protection Act |
E65826
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Ryan Haight Online Pharmacy Consumer Protection Act | Statement: [Ryan Haight, hasNameGivenTo, Ryan Haight Online Pharmacy Consumer Protection Act]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Ryan Haight Online Pharmacy Consumer Protection Act Context triple: [Ryan Haight, hasNameGivenTo, Ryan Haight Online Pharmacy Consumer Protection Act]
-
A.
Ryan Haight Online Pharmacy Consumer Protection Act of 2008
chosen
The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 is a U.S. federal law that regulates internet pharmacies by requiring valid prescriptions and in-person medical evaluations before dispensing controlled substances online.
-
B.
Prescription Drug User Fee Act of 1992
The Prescription Drug User Fee Act of 1992 is a U.S. law that authorizes the FDA to collect fees from pharmaceutical companies to fund and expedite the review of new drug applications.
-
C.
Food and Drug Administration Amendments Act of 2007
The Food and Drug Administration Amendments Act of 2007 is a U.S. law that expanded the FDA’s authority over drug and device safety, clinical trials, and post-market surveillance, while enhancing transparency and user fee programs.
-
D.
No Surprises Act
The No Surprises Act is a U.S. federal law that protects patients from unexpected out-of-network medical bills and limits balance billing in many emergency and non-emergency care situations.
-
E.
Drug Price Competition and Patent Term Restoration Act of 1984
The Drug Price Competition and Patent Term Restoration Act of 1984, commonly known as the Hatch-Waxman Act, is a U.S. law that streamlined the approval of generic drugs while providing patent term extensions to brand-name drug manufacturers to balance innovation and competition.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d81c58feb08190a77bca8bf7d6d20f |
completed | April 9, 2026, 9:38 p.m. |
| NER | Named-entity recognition | batch_69de0248db988190aa43c3723af25f90 |
completed | April 14, 2026, 9 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69f7b8d6b3c88190aa8fb72d8ad9644d |
completed | May 3, 2026, 9:06 p.m. |
Created at: April 9, 2026, 10:11 p.m.